2010
DOI: 10.1039/b920193a
|View full text |Cite
|
Sign up to set email alerts
|

Facile and rapid access to linear and truncated microcystin analogues for the implementation of immunoassays

Abstract: A series of simplified microcystin-LR analogues based on Adda [(2S,3S,8S,9S,4E,6E)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecadienoic acid] or its corresponding aldol precursor linked to a polypeptide moiety have been synthesised and assessed for their binding affinity by the monoclonal antibody mAb MC159, an anti-microcystin-LR mAb recently selected by us for the detection of microcystins through various immunoassay formats. Some modifications have been brought to the enantiospecific synthesis of N-Boc-Ad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 52 publications
0
7
0
Order By: Relevance
“…Several approaches for isotope incorporation are available, including synthetic, conjugative or by exchange reaction with the intact molecule. While the synthetic route involves straightforward coupling of 13 C- or 14 N-containing amino acids, a major difficulty lies in preparation of the ADDA amino acid which contains four chiral centers, representing a significant synthetic undertaking [48, 49]. Thus, chemical synthesis methodologies for MC standards are time and economically impractical since the measurement of endogenous MC congeners would require the separate synthesis of each variant.…”
Section: Resultsmentioning
confidence: 99%
“…Several approaches for isotope incorporation are available, including synthetic, conjugative or by exchange reaction with the intact molecule. While the synthetic route involves straightforward coupling of 13 C- or 14 N-containing amino acids, a major difficulty lies in preparation of the ADDA amino acid which contains four chiral centers, representing a significant synthetic undertaking [48, 49]. Thus, chemical synthesis methodologies for MC standards are time and economically impractical since the measurement of endogenous MC congeners would require the separate synthesis of each variant.…”
Section: Resultsmentioning
confidence: 99%
“…N a -(tert-Butyloxycarbonyl)-L-lysine carboxamide (Boc-Lys-NH 2 ) was prepared from commercially available N a -( tert -butyloxycarbonyl ) -N e -( benzyloxycarbonyl ) -L -lysine (Boc-Lys(Z)-OH, Bachem or Fluka), by using a conventional two-step synthetic procedure: aminolysis of mixed anhydride formed in situ by short treatment with isobutyl chloroformate and N-methylmorpholine (NMM), followed by hydrogenolysis to remove the Z protecting group. 23 The synthesis of dodecapeptides (N a -Ac-lysine-or aminooxyacetic acid-terminated) was carried out on an Applied Biosystems 433A peptide synthesizer using standard Fmoc/tBu chemistry 24 and Wang resin (Iris Biotech, loading 0.9 mmol g -1 ) on a scale of 0.25 mmol. The HPLCgradient grade acetonitrile (CH 3 CN) and methanol (CH 3 OH) were obtained from VWR.…”
Section: Discussionmentioning
confidence: 99%
“…A microcystin-LR analogue N -Boc-Adda [(2 S ,3 S ,8 S ,9 S ,4 E ,6 E )-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecadienoic acid] named GC300 was synthesized as previously described [10]. Ester-active GC300 was conjugated to insulin via its NH 2 function.…”
Section: Methodsmentioning
confidence: 99%